非结核分枝杆菌肺病治疗:ATS/ERS/ESCMID/IDSA 官方临床实践指南
该指南由 ATS、ERS、ESCMID 和 IDSA 联合制定,聚焦成人(无囊性纤维化或 HIV 感染)非结核分枝杆菌肺病,涵盖鸟分枝杆菌复合群、堪萨斯分枝杆菌、蟾蜍分枝杆菌和脓肿分枝杆菌等常见病原。
要点
- 指南针对成人非囊性纤维化、非 HIV 的 NTM 肺病,涵盖常见慢生长和快生长菌种。
- 推荐供感染病和肺病专科等照护 NTM 肺病患者的医疗人员使用。
研究设计与样本
- 由 ATS、ERS、ESCMID、IDSA 选出的多学科专家组制定,涵盖肺病、感染病、临床微生物、实验室医学和患者倡导领域。
- 围绕 22 个 PICO 问题开展系统评价,采用 GRADE 方法制定并分级推荐。
主要发现
- 指南聚焦鸟分枝杆菌复合群、堪萨斯分枝杆菌、蟾蜍分枝杆菌(慢生长)和脓肿分枝杆菌(快生长)所致成人肺病。
关键数值与推荐
- 推荐针对成人(无囊性纤维化或 HIV 感染)NTM 肺病,涉及鸟分枝杆菌复合群、堪萨斯分枝杆菌、蟾蜍分枝杆菌和脓肿分枝杆菌。
临床怎么用
- 供感染病和肺病专科等照护 NTM 肺病患者的医疗人员参考使用。
局限性
- 指南不涵盖囊性纤维化或 HIV 感染患者的 NTM 肺病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites. This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium xenopi among the slowly growing NTM and Mycobacterium abscessus among the rapidly growing NTM. A panel of experts was carefully selected by leading international respiratory medicine and infectious diseases societies (ATS, ERS, ESCMID, IDSA) and included specialists in pulmonary medicine, infectious diseases and clinical microbiology, laboratory medicine, and patient advocacy. Systematic reviews were conducted around each of 22 PICO (Population, Intervention, Comparator, Outcome) questions and the recommendations were formulated, written, and graded using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Thirty-one evidence-based recommendations about treatment of NTM pulmonary disease are provided. This guideline is intended for use by healthcare professionals who care for patients with NTM pulmonary disease, including specialists in infectious diseases and pulmonary diseases.
引用
- Daley CL, Iaccarino JM, Lange C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis. 2020. PMID: 32628747. doi:10.1093/cid/ciaa241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。